(Reuters) – AstraZeneca, Eli Lilly, Regeneron and GlaxoSmithKline are among the biggest players to have…
View More Factbox-Front runners in development of antibody drugs against COVID-19Home »
Clot-busting drug may be safe for people with stroke and unruptured aneurysms
Clot-busting drugs are the main treatment for stroke, but they have often not been recommended…
View More Clot-busting drug may be safe for people with stroke and unruptured aneurysmsAnti-cancer drug derived from fungus shows promise in clinical trials
A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found…
View More Anti-cancer drug derived from fungus shows promise in clinical trialsCommon diabetes drug shows promise against rare childhood brain tumor in laboratory studies
Metformin, a drug commonly prescribed against diabetes, holds promise against a rare type of childhood…
View More Common diabetes drug shows promise against rare childhood brain tumor in laboratory studiesCholesterol drug cuts coronavirus infection by 70%, researchers find
Hospital staff struggling as coronavirus hospitalizations spike West Coast correspondent Jeff Paul reports on some…
View More Cholesterol drug cuts coronavirus infection by 70%, researchers findUS drug firms face jury over opioid addiction epidemic
US pharmaceutical firms accused of stoking a two-decade epidemic of opioid addiction that has seen…
View More US drug firms face jury over opioid addiction epidemicNewly approved drug effective against lung cancer caused by genetic mutation
The new drug sotorasib reduces tumor size and shows promise in improving survival among patients…
View More Newly approved drug effective against lung cancer caused by genetic mutationImmunotherapy drug can beat back early-stage lung cancer
An immunotherapy drug is the first to significantly reduce the risk of cancer recurrence or…
View More Immunotherapy drug can beat back early-stage lung cancerNew experimental drug cagrilintide (AM833), when combined with emaglutide, shows potential for treatment of obesity
An early study of a new experimental drug to treat obesity known as cagrilintide shows…
View More New experimental drug cagrilintide (AM833), when combined with emaglutide, shows potential for treatment of obesityNew report finds COVID-19 pandemic causes dramatic shifts in prescription drug spending
The COVID-19 pandemic heavily influenced spending on prescription drugs in the U.S. in 2020, according…
View More New report finds COVID-19 pandemic causes dramatic shifts in prescription drug spending